GT-202

N/A

Report date: 2023/02/28 14:16:39

Base Information

Drug NameGT-202
Drug Alias NameGT-202
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Tumor Infiltrating Lymphocytes
Mechanisms of ActionT lymphocyte replacements
TargetsNot applicable
Therapy Area/IndicationsGenital Neoplasms, FemaleLung Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator Companiesshenzhen Grit Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active Companiesshenzhen Grit Biotechnology Co LtdObstetrics & Gynecology Hospital Of Fudan University，Shanghai Red House Obstetrics & Gynecology Hospital
Inactive CompaniesN/A
Active IndicationsGenital Neoplasms, FemaleLung Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A